Status:

COMPLETED

Evaluation of Spa Therapy in the Treatment of Fibromyalgia

Lead Sponsor:

Association Francaise pour la Recherche Thermale

Collaborating Sponsors:

Floralis

University Hospital, Grenoble

Conditions:

Fibromyalgia

Rheumatism, Muscular

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Fibromyalgia is a common health problem that causes widespread pain and tenderness (sensitive to touch). The pain and tenderness tend to come and go, and move about the body. There is no cure for fibr...

Detailed Description

THERMALGI is a controlled, randomized, multicentre, open label trial wich aims to evaluate the effects of spa therapy in rheumatologia on evolution of disability in daily life of patients with fibromy...

Eligibility Criteria

Inclusion

  • both sexes, more than 18 years old patients
  • available for a spa treatment in rheumatology during 18 days (immediate or late spa) and a follow-up period of 12 months
  • with fibromyalgia ( ACR criteria 2010) for at least 1 year and with a stable treatment for at least 3 months
  • with a FIQ score \> or = 39 (fibromyalgia moderate to severe)
  • voluntary to participate to the study, informed consent form signed after appropriate information
  • affiliation to the social security system or equivalent

Exclusion

  • contra-indication of spa treatment (cancer in progress, psychiatrics disorders, immunodeficiency)
  • no previous spa treatment in rheumatology within 1 year prior to inclusion
  • substantial variation of the therapeutic coverage in the previous 3 months the inclusion (change of medicinal class, starting up of a réentrainement in the effort or a cognitivio-behavioral technique)
  • subject with an other chronic severe disease (severe asthma, severe cardiac insuffisiancy, respiratory, renal or liver failures, evolutive rheumatic disease, inflammatory colitis...)
  • subject participating to an other clinical study inerventionnal
  • pregnancy, parturient or breast feeding
  • no psychiatric illness or social situation that would preclude study compliance

Key Trial Info

Start Date :

September 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2018

Estimated Enrollment :

220 Patients enrolled

Trial Details

Trial ID

NCT02265029

Start Date

September 1 2014

End Date

October 1 2018

Last Update

January 11 2019

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

station thermale AIX LES BAINS

Aix-les-Bains, France, 73100

2

station thermale ALLEVARD LES BAINS

Allevard, France, 38580

3

station thermale BOURBON LANCY

Bourbon-Lancy, France, 71140

4

station thermale LAMALOU LES BAINS

Lamalou-les-Bains, France, 34240